Site_Number,Institution,Region,Country,Subject ID Number,Subject_Current_Status,Active/Inactive,Age at Informed Consent,Gender,Race,Original Informed Consent Date,Screening Date,Enrollment_Date,Treatment Discontinuation Date
132,Site 132,South America,Brazil,1321132,On Treatment,Active,55,Male,Hispanic or Latino,27-Dec-21,24-Jan-22,9-Feb-22,
168,Site 168,Europe,United Kingdom,1681168,In Screening,Active,62,Male,White,23-Sep-22,6-Oct-22,4-Nov-22,
183,Site 183,Europe,France,1831183,In Follow Up,Active,65,Male,White,25-Nov-22,24-Dec-22,7-Jan-23,
195,Site 195,Europe,Spain,1951195,In Screening,Active,29,Female,White,3-Oct-23,23-Oct-23,24-Oct-23,
237,Site 237,Europe,Netherlands,2371237,In Follow Up,Active,41,Female,White,29-May-24,28-Jun-24,13-Jul-23,
241,Site 241,Europe,Sweden,2411241,In Follow Up,Active,42,Male,White,16-Apr-23,12-May-23,19-May-23,
256,Site 256,Europe,Switzerland,2561256,In Screening,Active,28,Female,White,10-May-22,29-May-22,30-May-22,
267,Site 267,Asia,Japan,2671267,In Follow Up,Active,32,Female,Asian,23-Dec-23,24-Dec-23,2-Jan-23,
285,Site 285,Asia,India,2851285,In Screening,Active,60,Male,Asian,12-Oct-24,16-Oct-24,27-Oct-23,
293,Site 293,Asia,Singapore,2931293,In Screening,Active,48,Male,Asian,17-May-20,21-May-20,16-Jun-20,
298,Site 298,Asia,Saudi Arabia,2981298,In Follow Up,Active,26,Female,Asian,7-Sep-23,9-Sep-23,8-Oct-23,
300,Site 301,Asia,United Arab Emirates,3011301,In Screening,Active,25,Male,Asian,4-Mar-21,13-Mar-21,27-Mar-21,
301,Site 301,Asia,Israel,3011301,In Screening,Active,45,Male,Asian,13-Jan-21,26-Jan-21,18-Feb-21,
306,Site 306,Asia,Turkey,3061306,In Screening,Active,29,Female,Asian,12-Apr-21,23-Apr-21,13-May-21,
347,Site 347,Africa,Ethiopia,3471347,In Follow Up,Active,43,Male,Black or African American,4-Feb-22,8-Feb-22,21-Feb-22,
357,Site 357,Oceania,Australia,3571357,In Screening,Active,59,Female,Native Hawaiian or Other Pacific Islander,23-May-24,30-May-24,15-Jun-23,
374,Site 374,Africa,Ghana ,3741374,In Follow Up,Active,61,Male,Black or African American,23-Jun-24,12-Jul-24,3-Aug-23,
391,Site 391,Central America,Costa Rica,3911391,On Treatment,Active,61,Female,Hispanic or Latino,23-Aug-21,5-Sep-21,2-Oct-21,
452,Site 452,Europe,Ukraine,4521452,In Follow Up,Active,40,Female,White,11-Jul-22,10-Aug-22,15-Aug-22,
460,Site 460,Europe,Hungary,4601460,In Follow Up,Active,34,Female,White,25-Sep-21,2-Oct-21,10-Oct-21,
469,Site 469,Asia,Kazakhstan,4691469,In Follow Up,Active,54,Male,Asian,24-Jun-20,16-Jul-20,19-Jul-20,
488,Site 488,Asia,Bangladesh,4881488,On Treatment,Active,40,Male,Asian,6-Nov-20,22-Nov-20,10-Dec-20,
492,Site 492,Asia,Pakistan,4921492,In Screening,Active,62,Female,Asian,1-Jan-24,14-Jan-24,16-Jan-23,
107,Site 107,North America,United States,1071107,Off Study,Inactive,52,Female,White,10-Mar-21,8-Apr-21,27-Apr-21,25-May-21
124,Site 124,North America,Canada,1241124,Off Study,Inactive,41,Male,White,1-Nov-24,9-Nov-24,2-Dec-23,4-Dec-23
154,Site 154,South America,Argentina,1541154,Screen Failed,Inactive,28,Female,Hispanic or Latino,5-Nov-20,27-Nov-20,3-Dec-20,15-Dec-20
156,Site 156,South America,Chile,1561156,Off Study,Inactive,62,Male,Hispanic or Latino,6-Apr-20,29-Apr-20,6-May-20,7-May-20
158,Site 158,South America,Colombia,1581158,Off Study,Inactive,30,Male,Hispanic or Latino,21-Sep-24,27-Sep-24,3-Oct-23,5-Oct-23
178,Site 178,Europe,Germany,1781178,Off Study,Inactive,37,Male,White,25-Jan-20,24-Feb-20,19-Mar-20,20-Mar-20
231,Site 231,Europe,Italy,2311231,Off Study,Inactive,57,Male,White,18-Mar-21,3-Apr-21,11-Apr-21,19-Apr-21
255,Site 255,Europe,Norway,2551255,Screen Failed,Inactive,57,Female,White,12-Sep-20,3-Oct-20,17-Oct-20,15-Nov-20
262,Site 262,Asia,China,2621262,Screen Failed,Inactive,41,Female,Asian,10-Mar-20,16-Mar-20,17-Mar-20,28-Mar-20
280,Site 280,Asia,South Korea,2801280,Screen Failed,Inactive,28,Female,Asian,31-Mar-23,27-Apr-23,10-May-23,9-Jun-23
294,Site 294,Asia,Malaysia,2941294,Off Study,Inactive,32,Male,Asian,24-Jun-23,26-Jun-23,20-Jul-23,6-Aug-23
295,Site 295,Asia,Thailand,2951295,Screen Failed,Inactive,28,Female,Asian,27-Jan-20,30-Jan-20,28-Feb-20,22-Mar-20
297,Site 298,Asia,Vietnam,2981298,Screen Failed,Inactive,32,Male,Asian,28-Jul-21,24-Aug-21,4-Sep-21,14-Sep-21
322,Site 322,Africa,South Africa,3221322,Screen Failed,Inactive,65,Male,Black or African American,22-Feb-20,1-Mar-20,24-Mar-20,22-Apr-20
323,Site 323,Africa,Egypt,3231323,Off Study,Inactive,44,Female,Black or African American,16-Jun-23,16-Jul-23,9-Aug-23,1-Sep-23
334,Site 334,Africa,Nigeria,3341334,Off Study,Inactive,37,Male,Black or African American,15-Feb-20,5-Mar-20,20-Mar-20,18-Apr-20
344,Site 344,Africa,Kenya,3441344,Screen Failed,Inactive,40,Female,Black or African American,7-Sep-21,19-Sep-21,13-Oct-21,4-Nov-21
366,Site 366,Oceania,New Zealand,3661366,Off Study,Inactive,25,Female,Native Hawaiian or Other Pacific Islander,22-May-20,30-May-20,24-Jun-20,7-Jul-20
381,Site 381,Africa,Morroco,3811381,Off Study,Inactive,33,Male,Black or African American,16-Mar-20,27-Mar-20,18-Apr-20,29-Apr-20
388,Site 388,Africa,Tanzania,3881388,Off Study,Inactive,27,Female,Black or African American,11-Apr-22,5-May-22,26-May-22,10-Jun-22
404,Site 404,Central America,Panama,4041404,Off Study,Inactive,35,Male,Hispanic or Latino,5-Jul-22,11-Jul-22,28-Jul-22,5-Aug-22
429,Site 429,Central America,Guatemala,4291429,Screen Failed,Inactive,42,Male,Hispanic or Latino,7-Dec-22,5-Jan-23,10-Jan-23,26-Jan-23
445,Site 445,Europe,Russia,4451445,Screen Failed,Inactive,48,Female,White,16-Oct-21,3-Nov-21,9-Nov-21,4-Dec-21
447,Site 447,Europe,Poland,4471447,Off Study,Inactive,62,Male,White,31-Aug-20,28-Sep-20,10-Oct-20,7-Nov-20
479,Site 479,Asia,Uzbekistan,4791479,Screen Failed,Inactive,39,Female,Asian,24-Jan-22,29-Jan-22,21-Feb-22,3-Mar-22
496,Site 496,Asia,Philippines,4961496,Screen Failed,Inactive,38,Male,Asian,2-Feb-21,14-Feb-21,3-Mar-21,26-Mar-21
